Revised SPC: Yescarta (axicabtagene ciloleucel) dispersion for infusion
Section 4.8 now includes dysphagia, quadriplegia, myelitis and spinal cord oedema as adverse drug reactions.
Source:
electronic Medicines compendium
Section 4.8 now includes dysphagia, quadriplegia, myelitis and spinal cord oedema as adverse drug reactions.
electronic Medicines compendium